banner add

Top Cancer Center Seeks to Retract or Correct Dozens of Studies

A British biologist and blogger discovered faulty data in many studies conducted by top executives of the Dana-Farber Cancer Institute.

from NYT > Health https://ift.tt/xNyCfeH
via IFTTT

No comments

China’s Rise in Drug Development Looms Over U.S.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is ...

Theme images by PLAINVIEW. Powered by Blogger.